Bullement, A.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Italian Cost Minimisation Analysis: Buccolam (Midazolam Oromucosal Solution) Versus Rectal Diazepam For Prolonged Acute Epileptic Seizures

Hatswell, A., Anelli, M., Vigevano, F., Saunders, A., Bullement, A., Lee, D.

Journal:

Value in Health

Year:

2014

Language:

english

File:

PDF, 63 KB

english, 2014

2

Cost Effectiveness of Characterised Chondrocyte Implantation for Treatment of Cartilage Defects of the Knee in the UK

Elvidge, Jamie, Bullement, Ash, Hatswell, Anthony J.

Journal:

PharmacoEconomics

Year:

2016

Language:

english

File:

PDF, 1.12 MB

english, 2016

3

An Exploration of Techniques for Addressing Uncertainty in Survival Estimates used Within Partitioned-Survival Models

Bullement, A, Critchlow, S

Journal:

Value in Health

Year:

2016

Language:

english

File:

PDF, 89 KB

english, 2016

4

Cost-effectiveness of Trifluridine/tipiracil for Previously Treated Metastatic Colorectal Cancer in England and Wales

Bullement, Ash, Underhill, Stuart, Fougeray, Ronan, Hatswell, Anthony James

Journal:

Clinical Colorectal Cancer

Year:

2017

Language:

english

File:

PDF, 542 KB

english, 2017

5

Cost Effectiveness of Nivolumab for Patients with Advanced, Previously Treated Renal Cell Carcinoma in Scotland

Mahon, S, Bullement, A, Willis, A, Sullivan, W, Britton, JA, Cox, L, Tyas, D, Sowdani, A

Journal:

Value in Health

Year:

2017

Language:

english

File:

PDF, 59 KB

english, 2017

6

Predicting Outcomes From Multiple Uncontrolled Historical Studies of Treatment of Physician’s Choice: Progression-Free Survival And Overall Survival In Untreated Metastatic Merkel Cell Carcinoma

Hatswell, AJ, Cooper, M, Bharmal, M, Bullement, A

Journal:

Value in Health

Year:

2017

Language:

english

File:

PDF, 60 KB

english, 2017

7

Probabilistic Sensitivity Analysis In Health Economic Models; How Many Simulations Should We Run?

Hatswell, AJ, Bullement, A, Paulden, M, Stevenson, M

Journal:

Value in Health

Year:

2017

Language:

english

File:

PDF, 55 KB

english, 2017

8

Probabilistic Sensitivity Analysis in Cost-Effectiveness Models: Determining Model Convergence in Cohort Models

Hatswell, Anthony J., Bullement, Ash, Briggs, Andrew, Paulden, Mike, Stevenson, Matthew D.

Journal:

PharmacoEconomics

Year:

2018

Language:

english

File:

PDF, 776 KB

english, 2018

9

A review and validation of overall survival extrapolation in health technology assessments of cancer immunotherapy by the National Institute for Health and Care Excellence: how did the initial best estimate compare to trial data subsequently made available?

Bullement, Ash, Meng, Yang, Cooper, Miranda, Lee, Dawn, Harding, Tara Louise, O'Regan, Chris, Aguiar-Ibanez, Raquel

Journal:

Journal of Medical Economics

Year:

2018

Language:

english

File:

PDF, 856 KB

english, 2018

10

Survival Extrapolation in Cancer Immunotherapy: A Validation-Based Case Study

Bullement, Ash, Latimer, Nicholas R., Bell Gorrod, Helen

Journal:

Value in Health

Year:

2018

Language:

english

File:

PDF, 851 KB

english, 2018

11

PRM135 - DICE FOR NICE? LESSONS FROM A SINGLE TECHNOLOGY APPRAISAL

Sullivan, W, Bullement, A, Lee, D

Journal:

Value in Health

Year:

2018

Language:

english

File:

PDF, 377 KB

english, 2018

12

How Errors in the Implementation of Background Mortality Leads to Bias in Models

Bullement, A, Hatswell, AJ

Journal:

Value in Health

Year:

2018

Language:

english

File:

PDF, 61 KB

english, 2018

13

NICE, in Confidence: An Assessment of Redaction to Obscure Confidential Information in Single Technology Appraisals by the National Institute for Health and Care Excellence

Bullement, Ash, Taylor, Matthew, McMordie, Sam Thomas, Waters, Errol, Hatswell, Anthony James

Journal:

PharmacoEconomics

Year:

2019

Language:

english

File:

PDF, 613 KB

english, 2019

14

Cost-Effectiveness Analysis of Recombinant Factor VIII Fc-Fusion Protein (rFVIIIFc) for the Treatment of Severe Hemophilia A in Italy Incorporating Real-World Dosing and Joint Health Data

Bullement, Ash, McMordie, Samuel Thomas, Hatswell, Anthony James, Li, Nanxin, Wilson, Koo

Journal:

PharmacoEconomics - Open

Year:

2019

Language:

english

File:

PDF, 710 KB

english, 2019

15

NICE, in Confidence: An Assessment of Redaction to Obscure Confidential Information in Single Technology Appraisals by the National Institute for Health and Care Excellence

Bullement, Ash, Taylor, Matthew, McMordie, Sam Thomas, Waters, Errol, Hatswell, Anthony James

Journal:

PharmacoEconomics

Year:

2019

File:

PDF, 613 KB

2019

16

A Review of Recent Decision-Analytic Models Used to Evaluate the Economic Value of Cancer Treatments

Bullement, Ash, Cranmer, Holly L., Shields, Gemma E.

Journal:

Applied Health Economics and Health Policy

Year:

2019

Language:

english

File:

PDF, 948 KB

english, 2019

17

RO4 COST-EFFECTIVENESS ANALYSIS OF RFVIIIFC, PEGYLATED RFVIII, AND EMICIZUMAB FOR THE PROPHYLACTIC TREATMENT OF SEVERE HEMOPHILIA A PATIENTS WITHOUT INHIBITORS IN THE UNITED STATES

Li, N., Bullement, A., McMordie, S., Hatswell, A.J., Wilson, K.

Journal:

Value in Health

Year:

2019

Language:

english

File:

PDF, 383 KB

english, 2019

18

ON4 REVIEW OF THE APPLICATION OF HEALTH-RELATED QUALITY OF LIFE (HRQOL) DATA IN RECENT HEALTH TECHNOLOGY ASSESSMENTS (HTAS) OF CANCER IMMUNOTHERAPIES (IOS) BY THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE)

Bullement, A., Shields, G., Hatswell, A.J., Schlichting, M., Bharmal, M.

Journal:

Value in Health

Year:

2019

Language:

english

File:

PDF, 378 KB

english, 2019

19

RO4 COST-EFFECTIVENESS ANALYSIS OF RFVIIIFC, PEGYLATED RFVIII, AND EMICIZUMAB FOR THE PROPHYLACTIC TREATMENT OF SEVERE HEMOPHILIA A PATIENTS WITHOUT INHIBITORS IN THE UNITED STATES

Li, N., Bullement, A., McMordie, S., Hatswell, A.J., Wilson, K.

Journal:

Value in Health

Year:

2019

File:

PDF, 383 KB

2019

20

1291PCost-effectiveness (CE) of avelumab vs standard care (SC) for the treatment of patients (pts) with metastatic Merkel cell carcinoma (mMCC)

Bharmal, M, Amin, A, Stapelkamp, C, Pescott, C, Hatswell, A, Lilley, C, Bullement, A, Willis, A

Journal:

Annals of Oncology

Year:

2018

File:

PDF, 76 KB

2018

21

PCN259 SHOULD HEALTH STATE UTILITY VALUES (HSUVS) IN CANCER IMMUNOTHERAPIES (IOS) BE ANALYZED BY TIME TO DEATH (TTD) OR PROGRESSION STATUS? RESULTS OF A SIMULATION STUDY

Hatswell, A.J., Bullement, A., Schlichting, M., Bharmal, M.

Journal:

Value in Health

Year:

2019

Language:

english

File:

PDF, 379 KB

english, 2019

22

“Stick or Twist?” Negotiating Price and Data in an Era of Conditional Approval

Gladwell, Daniel, Bullement, Ash, Cowell, Warren, Patterson, Karl, Strong, Mark

Journal:

Value in Health

Year:

2019

File:

PDF, 1.30 MB

2019

23

PCN103 A COMPARISON OF PARTITIONED-SURVIVAL AND STATE TRANSITION MODELLING APPROACHES - FINDINGS FROM A CASE STUDY IN ONCOLOGY

Cranmer, H., Shields, G., Bullement, A.

Journal:

Value in Health

Year:

2019

File:

PDF, 381 KB

2019

24

PCN224 TREATMENT BENEFIT DISCONTINUATION: COMPARISON OF A PARTITIONED SURVIVAL ANALYSIS AND A SEMI-MARKOV MULTI-STATE MODEL APPROACH USING AN ONCOLOGY CASE STUDY

Cranmer, H., Shields, G., Bullement, A.

Journal:

Value in Health

Year:

2019

File:

PDF, 315 KB

2019

25

PDB32 WOULD A COHORT-LEVEL APPROACH TO COST-EFFECTIVENESS MODELLING HAVE LED TO A DIFFERENT DECISION IN AN IMPORTANT NICE APPRAISAL FOR OBESITY PATIENTS?

Metry, A., Sullivan, W., Kearns, B.C., Bullement, A.

Journal:

Value in Health

Year:

2019

File:

PDF, 715 KB

2019

26

Evaluation of survival extrapolation in immuno-oncology using multiple pre-planned data cuts: learnings to aid in model selection

Bullement, Ash, Willis, Anna, Amin, Amerah, Schlichting, Michael, Hatswell, Anthony James, Bharmal, Murtuza

Journal:

BMC Medical Research Methodology

Year:

2020

File:

PDF, 944 KB

2020

27

Real-world evidence use in assessments of cancer drugs by NICE

Bullement, Ash, Podkonjak, Tanja, Robinson, Mark J., Benson, Eugene, Selby, Ross, Hatswell, Anthony J., Shields, Gemma E.

Journal:

International Journal of Technology Assessment in Health Care

Year:

2020

File:

PDF, 293 KB

2020

28

A comparison of partitioned survival analysis and state transition multi-state modelling approaches using a case study in oncology

Cranmer, Holly, Shields, Gemma E., Bullement, Ash

Journal:

Journal of Medical Economics

Year:

2020

File:

PDF, 2.03 MB

2020

29

Voretigene Neparvovec for Treating Inherited Retinal Dystrophies Caused by RPE65 Gene Mutations: An Evidence Review Group Perspective of a NICE Highly Specialised Technology Appraisal

Farmer, Caroline, Bullement, Ash, Packman, David, Long, Linda, Robinson, Sophie, Nikram, Elham, Hatswell, Anthony J., Melendez-Torres, G. J., Crathorne, Louise

Journal:

PharmacoEconomics

Year:

2020

File:

PDF, 671 KB

2020